ARPE-19-Cas9 Cell Line

Product Name	ARPE-19-Cas9 Cell Line
Cat.No	RG-110
Size	1*10^6 cells/vial
Description	ARPE-19-Cas9 Cell Line was constructed using Cas9 gene expressing lentivirus. Cas9 protein was stably expressed, and the Cas9 stable cell line is validated by RT-QPCR and gene editing experiments. ARPE-19-Cas9 Stable Cell Line, ARPE-19-Cas9 can be used to carry out CRISPR genome editing applications with high efficiency; to make Gene editing (knockout, point mutation and tag knockin); and as a platform to optimize CRISPR library screening.
Species	Human
Full Name	ARPE-19-Cas9 Stable Cell Line
Parental Cell Line	ARPE-19 Cell Line
Biosafety Level	BSL 2. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Expression Gene	Cas9
Morphology	Endothelial cells, adherent
Passage Ratio	1:3~1:5
Culture Method	90% DMEM/F12+10% FBS
Quality Control	ARPE-19-Cas9 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	ARPE-19-Cas9 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	This cell line is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

ARPE-19-Cas9 Cell Line

Online Inquiry

Online Inquiry